4
Changes in Ownership
Seres Therapeutics, Inc. Filed Acc 0001209191-15-057197
President and CEO acquired 22,727 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Pomerantz Roger · President and CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2015-06-26 | Conversion : show line 1 in the form | +22,727 | 22,727 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Underlying | Owned after | D/I |
|---|---|---|---|---|---|
| 2015-06-26 | Conversion : show line 2 in the form Series B Convertible Preferred Stock | −22,727 | 22,727 | 0 | D |
Loading xslF345X03/doc4.xml…